Home > Insider Trading > Filing (0001181431-11-024257)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1138776	Medgenics Inc.	MDGN	Biological Products, (No Disgnostic Substances) (2836)	980217544

Insiders

Cik	Name	Reported Address	Director	Officer	Large Shareholder	Other
905536	Isaac Blech	75 Rockefeller Plaza, 29Th Floor New York NY 10019	No	No	Yes	No
1514430	Blech Isaac F/B/O Trust Remainder Charitable Liberty	75 Rockefeller Plaza, 29Th Floor New York NY 10019	No	No	No	Yes
1514431	Blech Isaac F/B/O Unitrust Remainder Charitable River	75 Rockefeller Plaza, 29Th Floor New York NY 10019	No	No	Yes	No
1518076	Unitrust Remainder Charitable West	75 Rockefeller Plaza, 29Th Floor New York NY 10019	No	No	No	Yes

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.00001 Per Share	Acquisiton	2011-04-13	1,000,000	$5.00	1,000,000	No	4	P	Indirect	By Trust
Common Stock, Par Value $0.00001 Per Share	Acquisiton	2011-04-13	644,053	$3.41	1,644,053	No	4	C	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Trust
No	4	C	Indirect	By Trust

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	2010 Convertible Debenture	Disposition	2011-04-13	1	$0.00	644,053	$3.41
Common Stock	Stock Option (right to buy)	Acquisiton	2011-03-23	19,068	$0.00	19,068	$6.65

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2010-09-22		No	4	C	Indirect
19,068		2020-12-10	No	4	A	Direct

Footnotes

The $2,150,000 Convertible Debenture, together with accrued interest thereon, automatically converted into shares of common stock of Medgenics, Inc. (the "Issuer") upon the closing of the Issuer's initial public offering at a conversion price of $3.405, which was related to the price that the Issuer's common stock was sold in the initial public offering. The Convertible Debenture had no stated expiration date.
The Stock Option vests in three (3) equal annual installments commencing on December 10, 2011.
Liberty Charitable Remainder Trust FBO Isaac Blech UAD 01/09/87 ("Liberty Trust") and West Charitable Remainder Unitrust ("West Trust") are the beneficial owners of less than 10% of the Issuer's common stock. Isaac Blech is the sole trustee of the Liberty Trust and the West Trust.